Acute Migraine

Zecuity Acute Migraine Patch No Longer Available

Zecuity Acute Migraine Patch No Longer Available

By

The FDA has posted a discontinuation notice for Zecuity, an iontophoretic transdermal system for the treatment for acute migraine in adults.

Anti-CGRP Receptor Antibody Erenumab Reduces Monthly Migraine Days

Anti-CGRP Receptor Antibody Erenumab Reduces Monthly Migraine Days

By

In a phase 3 trial, treatment with erenumab reduced migraine frequency, monthly migraine days, and migraine medication use in patients with episodic migraine.

Migraine Treatment During Pregnancy Linked to Adverse Events

Migraine Treatment During Pregnancy Linked to Adverse Events

By

Pregnant women who seek treatment for acute migraine may experience higher rates of preterm delivery, preeclampsia, and low birth weight compared with the general population.

Sign Up for Free e-Newsletters